Frankfurt - Delayed Quote EUR
Amedisys, Inc. (ADY.F)
81.50
+0.50
+(0.62%)
At close: May 23 at 3:57:39 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,371,691
2,348,324
2,236,382
2,223,199
2,214,112
Cost of Revenue
1,343,160
1,330,647
1,245,509
1,260,425
1,233,356
Gross Profit
1,028,531
1,017,677
990,873
962,774
980,756
Operating Expense
811,122
808,110
797,807
778,993
728,841
Operating Income
217,409
209,567
193,066
183,781
251,915
Net Non Operating Interest Income Expense
-19,811
-22,654
-28,004
-22,050
-9,476
Other Income Expense
-47,404
-100,697
-125,439
-1,487
37,792
Pretax Income
150,194
86,216
39,623
160,244
280,231
Tax Provision
64,805
48,054
50,559
42,545
70,065
Net Income Common Stockholders
89,843
43,231
-9,747
118,609
209,072
Diluted NI Available to Com Stockholders
89,843
43,231
-9,747
118,609
209,072
Basic EPS
2.74
--
-0.30
3.65
6.41
Diluted EPS
2.71
--
-0.30
3.63
6.34
Basic Average Shares
32,748.75
--
32,599
32,517
32,642
Diluted Average Shares
33,110.75
--
32,599
32,653
32,972
Total Operating Income as Reported
106,278
94,538
156,394
180,772
251,915
Total Expenses
2,154,282
2,138,757
2,043,316
2,039,418
1,962,197
Net Income from Continuing & Discontinued Operation
89,843
43,231
-9,747
118,609
209,072
Normalized Income
156,521.60
134,103.91
102,963.88
120,820.62
185,748.50
Interest Income
9,256
8,110
3,270
178
49
Interest Expense
29,067
30,764
31,274
22,228
9,525
Net Interest Income
-19,811
-22,654
-28,004
-22,050
-9,476
EBIT
179,261
116,980
70,897
182,472
289,756
EBITDA
240,450
177,441
128,740
253,436
361,021
Reconciled Cost of Revenue
1,300,144
1,288,183
1,205,413
1,214,396
1,192,992
Reconciled Depreciation
61,189
60,461
57,843
70,964
71,265
Net Income from Continuing Operation Net Minority Interest
89,843
43,231
-9,747
118,609
209,072
Total Unusual Items Excluding Goodwill
-111,131
-115,029
-142,672
-3,009
31,098
Total Unusual Items
-111,131
-115,029
-142,672
-3,009
31,098
Normalized EBITDA
351,581
292,470
271,412
256,445
329,923
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-44,452.40
-24,156.09
-29,961.12
-797.39
7,774.50
12/31/2021 - 7/1/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade